Good result for Q2 this year....some more they have contract supply to the govt for some diabetes medicine...with very good margin..

agreed with mmtalents. that's their modus operandi & yet can pittance dividend of 3.41 sen. To me they are too good in $ management whereby leakages is plentiful & with poor investment especially in their injectable plant project.

Fully agreed with setia2u....tough nut to crack & eat counter...something not right with the current management . got good manufacturing contract & yet cannot make profit....wonder they have something unable to review....anyway poor record history if one can remember Carotide - delisted finally

Very doubtful that this new model Suprima will do well in the future. If one look at its fuel consumption of 9.1 lit/100km, its considered very high among the other non-national 1.6cc models. Imagine paying almost 20 sen per km is too high for normal usage...

Useless management team...got govt concession biz also lose $$$$$...what the heck have they done this qtr....their logistic dept used to be very efficient but not now ..with so much obsolete products meant poor SCM guys...pls buck up or else...QTR 3 result will be worse...

Hope it's not a flash in the pan....gone the next minute

Agreed fully with Alpacino. No doubt about Pharmaniaga hitting RM10 in the long term. I had been keeping it for the past 10yrs with very good dividend every year since. Real pity for those who play contra....

tks alpacino...don't bother abt tansrishare comment...already have accumulated tons of Biosis share & happy to pick up more if it drops further...to let u know I am in the pharma industry long enough.

Wah that's very good news...PN 17 will be out soon....better queue up to buy some more before it's too late....already missed the boat earlier. Since Biosis is planning to work with Pharmaniaga & both are bumi company, I see no problem for it to go up again back to its glory day.